Perrigo Company plc Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Perrigo Company plc (PRGO) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $360.80 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2023-02-28
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $360.80M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $341.70M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $390.10M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $373.30M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2022-12-31 | $360.80M 10-K · filed 2023-02-28 | |
| 2021-12-31 | $341.70M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $390.10M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $373.30M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $359.20M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $292.50M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $292.40M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $244.20M 10-K · filed 2018-03-01 | $243.60M 10-KT · filed 2016-02-25 |
| 2015-06-27 | $232.40M 10-K · filed 2017-05-22 | $502.40M 10-K · filed 2015-08-13 |
| 2014-06-28 | $47.10M 10-KT · filed 2016-02-25 | $300.40M 10-K · filed 2014-08-14 |
| 2013-06-29 | $31.30M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |